Publications by authors named "Robyn Mellett"

Claim this Profile
P
Prevalence and Impact of Bypassing or Overriding Phase 2 Trials in Neurologic Drug Development.
Hannah Moyer, Robyn Mellett, Karine Vigneault, Maya McKeown, Jason Karlawish

Neurologyยท July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis